

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of autophagic vacuole assembly (GO:2000785) | 5.69188054 |
| 2 | regulation of vacuole organization (GO:0044088) | 5.03273485 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.94284973 |
| 4 | protein localization to cilium (GO:0061512) | 4.93412412 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.91148260 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.91148260 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.55031221 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 4.15560528 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.14032231 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.08203318 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.08203318 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.08203318 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.08203318 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.08203318 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.08203318 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.07374535 |
| 17 | negative regulation of granulocyte differentiation (GO:0030853) | 4.06687865 |
| 18 | activated T cell proliferation (GO:0050798) | 4.05497540 |
| 19 | keratinocyte development (GO:0003334) | 3.98259483 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74995936 |
| 21 | negative regulation of gluconeogenesis (GO:0045721) | 3.63607288 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.62005794 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.60805329 |
| 24 | detection of other organism (GO:0098543) | 3.57720649 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.55556951 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 3.51248957 |
| 27 | response to host immune response (GO:0052572) | 3.43341504 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.43341504 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42831336 |
| 30 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.42235667 |
| 31 | detection of bacterium (GO:0016045) | 3.40224241 |
| 32 | neutrophil mediated immunity (GO:0002446) | 3.36438613 |
| 33 | respiratory burst (GO:0045730) | 3.27526597 |
| 34 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.26857066 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.26251146 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.24074838 |
| 37 | neutrophil activation (GO:0042119) | 3.21407877 |
| 38 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.20117907 |
| 39 | leukocyte aggregation (GO:0070486) | 3.20031384 |
| 40 | response to peptidoglycan (GO:0032494) | 3.19438070 |
| 41 | cellular response to type I interferon (GO:0071357) | 3.18339642 |
| 42 | type I interferon signaling pathway (GO:0060337) | 3.18339642 |
| 43 | centrosome localization (GO:0051642) | 3.18234869 |
| 44 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.15638866 |
| 45 | response to type I interferon (GO:0034340) | 3.14651965 |
| 46 | detection of molecule of bacterial origin (GO:0032490) | 3.13871557 |
| 47 | positive thymic T cell selection (GO:0045059) | 3.11644313 |
| 48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11510091 |
| 49 | response to host (GO:0075136) | 3.11510091 |
| 50 | response to host defenses (GO:0052200) | 3.11510091 |
| 51 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10903040 |
| 52 | detection of external biotic stimulus (GO:0098581) | 3.10502667 |
| 53 | microglial cell activation (GO:0001774) | 3.09351051 |
| 54 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.03351500 |
| 55 | negative regulation of innate immune response (GO:0045824) | 3.00920535 |
| 56 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.98285779 |
| 57 | response to interleukin-15 (GO:0070672) | 2.97853272 |
| 58 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.94522683 |
| 59 | adaptation of signaling pathway (GO:0023058) | 2.92089543 |
| 60 | response to muramyl dipeptide (GO:0032495) | 2.90706141 |
| 61 | regulation of granulocyte differentiation (GO:0030852) | 2.90489497 |
| 62 | cellular extravasation (GO:0045123) | 2.89843093 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 2.85532396 |
| 64 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.84682291 |
| 65 | myeloid leukocyte mediated immunity (GO:0002444) | 2.84451279 |
| 66 | negative regulation of interleukin-6 production (GO:0032715) | 2.81709061 |
| 67 | regulation of protein polyubiquitination (GO:1902914) | 2.81525222 |
| 68 | myeloid cell activation involved in immune response (GO:0002275) | 2.80300691 |
| 69 | regulation of regulatory T cell differentiation (GO:0045589) | 2.79421328 |
| 70 | granulocyte activation (GO:0036230) | 2.79132841 |
| 71 | actin filament polymerization (GO:0030041) | 2.78908446 |
| 72 | cellular response to interleukin-15 (GO:0071350) | 2.78832383 |
| 73 | macrophage activation (GO:0042116) | 2.77578499 |
| 74 | SMAD protein complex assembly (GO:0007183) | 2.76284155 |
| 75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.73549164 |
| 76 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.71898394 |
| 77 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.71637518 |
| 78 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.71239849 |
| 79 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.71239849 |
| 80 | B cell receptor signaling pathway (GO:0050853) | 2.70129726 |
| 81 | response to interferon-beta (GO:0035456) | 2.69186109 |
| 82 | negative thymic T cell selection (GO:0045060) | 2.68631002 |
| 83 | regulation of B cell differentiation (GO:0045577) | 2.68433226 |
| 84 | detection of biotic stimulus (GO:0009595) | 2.67824882 |
| 85 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.65882330 |
| 86 | negative regulation of T cell mediated immunity (GO:0002710) | 2.65014956 |
| 87 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.64940752 |
| 88 | interferon-gamma production (GO:0032609) | 2.61848615 |
| 89 | negative T cell selection (GO:0043383) | 2.61586563 |
| 90 | positive T cell selection (GO:0043368) | 2.59361621 |
| 91 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.58267590 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.55712694 |
| 93 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.54133390 |
| 94 | xenobiotic catabolic process (GO:0042178) | 2.53874716 |
| 95 | positive regulation of mast cell activation (GO:0033005) | 2.53629708 |
| 96 | tolerance induction (GO:0002507) | 2.53547492 |
| 97 | defense response to protozoan (GO:0042832) | 2.52842942 |
| 98 | germinal center formation (GO:0002467) | 2.52451893 |
| 99 | autophagic vacuole fusion (GO:0000046) | 2.51864870 |
| 100 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.51632200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.63498401 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.42918317 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.31325791 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.29085487 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.82566667 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.71336511 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.50330296 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.50291514 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50254122 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.38212612 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.35629878 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.32287530 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23014302 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22979930 |
| 15 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09394793 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05118147 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.95107658 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.94468798 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93737812 |
| 20 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93197218 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90770539 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88554342 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87475368 |
| 24 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84526954 |
| 25 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.80884754 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.79068824 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.75944096 |
| 28 | MAF_26560356_Chip-Seq_TH2_Human | 1.75148140 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73480559 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72050090 |
| 31 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.72036112 |
| 32 | * MYB_26560356_Chip-Seq_TH1_Human | 1.65845318 |
| 33 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.58173674 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53802365 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50521545 |
| 36 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48752100 |
| 37 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.48500310 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47429943 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46981893 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45527323 |
| 41 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.40955301 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.40497367 |
| 43 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39309531 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.37760648 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.37260156 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.36975206 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36925259 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35145122 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33187653 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33095213 |
| 51 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.32298197 |
| 52 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.31260132 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30749472 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29441760 |
| 55 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28290075 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27889122 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27315254 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27195871 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26549424 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24882995 |
| 61 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.22830381 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22625427 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19176800 |
| 64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15031586 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14719467 |
| 66 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11663234 |
| 67 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10448063 |
| 68 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08801411 |
| 69 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.08341715 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.08256759 |
| 71 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.07503917 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07340936 |
| 73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07044106 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06837531 |
| 75 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.05865668 |
| 76 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05701003 |
| 77 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04326212 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04309580 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04233094 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03975143 |
| 81 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03634533 |
| 82 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03614733 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02942111 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02396713 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01963967 |
| 86 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01704819 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01572373 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01547849 |
| 89 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.01211334 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01043638 |
| 91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00532566 |
| 92 | P300_27268052_Chip-Seq_Bcells_Human | 0.99693520 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99020210 |
| 94 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.93987467 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93427425 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93347808 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92012309 |
| 98 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90503765 |
| 99 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90236762 |
| 100 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90060370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.93298489 |
| 2 | MP0003436_decreased_susceptibility_to | 3.61428495 |
| 3 | MP0003303_peritoneal_inflammation | 2.89633157 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.88905839 |
| 5 | MP0002419_abnormal_innate_immunity | 2.65720092 |
| 6 | MP0009278_abnormal_bone_marrow | 2.47494101 |
| 7 | MP0001800_abnormal_humoral_immune | 2.45539253 |
| 8 | MP0005025_abnormal_response_to | 2.39754280 |
| 9 | MP0001790_abnormal_immune_system | 2.39231523 |
| 10 | MP0005387_immune_system_phenotype | 2.39231523 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.36180127 |
| 12 | MP0002723_abnormal_immune_serum | 2.26577611 |
| 13 | MP0009785_altered_susceptibility_to | 2.22381344 |
| 14 | MP0000685_abnormal_immune_system | 2.22260865 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.19309901 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.17200993 |
| 17 | MP0001819_abnormal_immune_cell | 2.14119093 |
| 18 | MP0005671_abnormal_response_to | 2.13765104 |
| 19 | MP0003183_abnormal_peptide_metabolism | 2.11751356 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.08838808 |
| 21 | MP0001986_abnormal_taste_sensitivity | 1.99868519 |
| 22 | MP0001533_abnormal_skeleton_physiology | 1.97482308 |
| 23 | MP0006082_CNS_inflammation | 1.80286281 |
| 24 | MP0002132_abnormal_respiratory_system | 1.78431830 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.77860451 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 1.77860451 |
| 27 | MP0002405_respiratory_system_inflammati | 1.72212752 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.68111760 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.67338586 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.65501557 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.63411915 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.60220782 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.58726167 |
| 34 | MP0000716_abnormal_immune_system | 1.58414053 |
| 35 | MP0003195_calcinosis | 1.52833871 |
| 36 | MP0009764_decreased_sensitivity_to | 1.51438550 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.50275499 |
| 38 | MP0008469_abnormal_protein_level | 1.49818020 |
| 39 | MP0002398_abnormal_bone_marrow | 1.46269744 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.44234333 |
| 41 | MP0002653_abnormal_ependyma_morphology | 1.43262163 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.36629211 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.34789522 |
| 44 | MP0002722_abnormal_immune_system | 1.28229789 |
| 45 | MP0003787_abnormal_imprinting | 1.27444345 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.27045702 |
| 47 | MP0003828_pulmonary_edema | 1.23333212 |
| 48 | MP0004883_abnormal_blood_vessel | 1.22976456 |
| 49 | MP0004381_abnormal_hair_follicle | 1.21941355 |
| 50 | MP0000343_altered_response_to | 1.20600204 |
| 51 | MP0004142_abnormal_muscle_tone | 1.19648988 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.19080688 |
| 53 | MP0005310_abnormal_salivary_gland | 1.18533211 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.17223442 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.16913280 |
| 56 | MP0000604_amyloidosis | 1.15419713 |
| 57 | MP0002429_abnormal_blood_cell | 1.15293699 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.12842337 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.09612780 |
| 60 | MP0004130_abnormal_muscle_cell | 1.09351641 |
| 61 | MP0003866_abnormal_defecation | 1.06523563 |
| 62 | MP0005365_abnormal_bile_salt | 1.06175698 |
| 63 | MP0003075_altered_response_to | 1.05198913 |
| 64 | MP0004484_altered_response_of | 1.05039671 |
| 65 | MP0005535_abnormal_body_temperature | 1.04296722 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.03988012 |
| 67 | MP0005083_abnormal_biliary_tract | 1.02570923 |
| 68 | MP0003329_amyloid_beta_deposits | 0.99872447 |
| 69 | MP0000703_abnormal_thymus_morphology | 0.98433838 |
| 70 | MP0003878_abnormal_ear_physiology | 0.98356593 |
| 71 | MP0005377_hearing/vestibular/ear_phenot | 0.98356593 |
| 72 | MP0009840_abnormal_foam_cell | 0.96181841 |
| 73 | MP0004947_skin_inflammation | 0.93850118 |
| 74 | MP0002909_abnormal_adrenal_gland | 0.93841738 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.91167280 |
| 76 | MP0001663_abnormal_digestive_system | 0.91083416 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 0.89613760 |
| 78 | MP0002971_abnormal_brown_adipose | 0.89289142 |
| 79 | MP0002837_dystrophic_cardiac_calcinosis | 0.87724028 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86823715 |
| 81 | MP0002928_abnormal_bile_duct | 0.86149700 |
| 82 | MP0003011_delayed_dark_adaptation | 0.85374646 |
| 83 | MP0005166_decreased_susceptibility_to | 0.84930020 |
| 84 | MP0002118_abnormal_lipid_homeostasis | 0.83951403 |
| 85 | MP0005390_skeleton_phenotype | 0.81155284 |
| 86 | MP0002102_abnormal_ear_morphology | 0.81029118 |
| 87 | MP0008260_abnormal_autophagy | 0.80306293 |
| 88 | MP0008004_abnormal_stomach_pH | 0.79779295 |
| 89 | MP0002933_joint_inflammation | 0.78615673 |
| 90 | MP0009763_increased_sensitivity_to | 0.76942845 |
| 91 | MP0002693_abnormal_pancreas_physiology | 0.76162499 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.75282057 |
| 93 | MP0004510_myositis | 0.72455442 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.72324531 |
| 95 | MP0005164_abnormal_response_to | 0.72292582 |
| 96 | MP0001851_eye_inflammation | 0.71774411 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.71755183 |
| 98 | MP0002166_altered_tumor_susceptibility | 0.71126967 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.70384544 |
| 100 | MP0003690_abnormal_glial_cell | 0.69772792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.23390026 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.83613705 |
| 3 | Myositis (HP:0100614) | 4.71277807 |
| 4 | Orchitis (HP:0100796) | 4.39454147 |
| 5 | Stomatitis (HP:0010280) | 4.33288893 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.20999262 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.18033050 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.13084225 |
| 9 | Optic neuritis (HP:0100653) | 4.08403153 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.08403153 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 4.08066248 |
| 12 | Abnormality of macrophages (HP:0004311) | 3.95580505 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.65260452 |
| 14 | Obstructive lung disease (HP:0006536) | 3.65260452 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.45735380 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.44405217 |
| 17 | Increased IgM level (HP:0003496) | 3.38064586 |
| 18 | Hypochromic microcytic anemia (HP:0004840) | 3.27631851 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.22381965 |
| 20 | Encephalitis (HP:0002383) | 3.20866234 |
| 21 | Episodic fever (HP:0001954) | 3.15044855 |
| 22 | Gastrointestinal infarctions (HP:0005244) | 3.08069933 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.06334566 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.06334566 |
| 25 | Recurrent skin infections (HP:0001581) | 2.98880527 |
| 26 | Meningitis (HP:0001287) | 2.95642414 |
| 27 | Hypochromic anemia (HP:0001931) | 2.86444377 |
| 28 | Progressive neurologic deterioration (HP:0002344) | 2.85437641 |
| 29 | Acute hepatic failure (HP:0006554) | 2.69336626 |
| 30 | Keratoconjunctivitis sicca (HP:0001097) | 2.68422215 |
| 31 | Vasculitis (HP:0002633) | 2.66052781 |
| 32 | Urticaria (HP:0001025) | 2.64817940 |
| 33 | Petechiae (HP:0000967) | 2.61141384 |
| 34 | Brushfield spots (HP:0001088) | 2.57914669 |
| 35 | Infantile muscular hypotonia (HP:0008947) | 2.53273282 |
| 36 | Increased IgE level (HP:0003212) | 2.52427386 |
| 37 | Prolonged bleeding time (HP:0003010) | 2.51354147 |
| 38 | Keratoconjunctivitis (HP:0001096) | 2.50133862 |
| 39 | Gingival bleeding (HP:0000225) | 2.48059848 |
| 40 | Hemoptysis (HP:0002105) | 2.37449396 |
| 41 | Prolonged neonatal jaundice (HP:0006579) | 2.36311723 |
| 42 | Chest pain (HP:0100749) | 2.33814886 |
| 43 | Pulmonary embolism (HP:0002204) | 2.31726079 |
| 44 | Arterial thrombosis (HP:0004420) | 2.29393282 |
| 45 | Inflammation of the large intestine (HP:0002037) | 2.28042329 |
| 46 | Gingivitis (HP:0000230) | 2.26739440 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.26220401 |
| 48 | Agammaglobulinemia (HP:0004432) | 2.21452484 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.17422829 |
| 50 | Chronic otitis media (HP:0000389) | 2.16644245 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 2.16638818 |
| 52 | Colitis (HP:0002583) | 2.14238042 |
| 53 | Leukocytosis (HP:0001974) | 2.12806268 |
| 54 | Abnormality of T cells (HP:0002843) | 2.12477245 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.11188168 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.10572927 |
| 57 | Epistaxis (HP:0000421) | 2.09646369 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09128631 |
| 59 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09128631 |
| 60 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09128631 |
| 61 | Visual hallucinations (HP:0002367) | 2.05863164 |
| 62 | Hematochezia (HP:0002573) | 2.04594536 |
| 63 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02560651 |
| 64 | Hypergammaglobulinemia (HP:0010702) | 2.01985380 |
| 65 | Anorexia (HP:0002039) | 2.01052612 |
| 66 | Loss of speech (HP:0002371) | 2.00442220 |
| 67 | Granulocytopenia (HP:0001913) | 1.98510948 |
| 68 | Purpura (HP:0000979) | 1.98490338 |
| 69 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95505575 |
| 70 | Mucopolysacchariduria (HP:0008155) | 1.95505575 |
| 71 | Cellulitis (HP:0100658) | 1.95147841 |
| 72 | Choroideremia (HP:0001139) | 1.94650486 |
| 73 | Pustule (HP:0200039) | 1.92443553 |
| 74 | Severe visual impairment (HP:0001141) | 1.92289986 |
| 75 | Osteomyelitis (HP:0002754) | 1.90337317 |
| 76 | Dysostosis multiplex (HP:0000943) | 1.89665835 |
| 77 | Amyloidosis (HP:0011034) | 1.89651953 |
| 78 | Acne (HP:0001061) | 1.89404399 |
| 79 | Keratitis (HP:0000491) | 1.89323794 |
| 80 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.88529202 |
| 81 | Microcytic anemia (HP:0001935) | 1.88398919 |
| 82 | Abnormality of the pleura (HP:0002103) | 1.88059671 |
| 83 | Recurrent sinusitis (HP:0011108) | 1.87878553 |
| 84 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.87209369 |
| 85 | Abnormality of glycolipid metabolism (HP:0010969) | 1.87209369 |
| 86 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.87209369 |
| 87 | Lissencephaly (HP:0001339) | 1.86172787 |
| 88 | Gangrene (HP:0100758) | 1.86051035 |
| 89 | Increased serum ferritin (HP:0003281) | 1.85829472 |
| 90 | Absent/shortened dynein arms (HP:0200106) | 1.85609165 |
| 91 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.85609165 |
| 92 | Alveolar cell carcinoma (HP:0006519) | 1.84955589 |
| 93 | Abnormality of iron homeostasis (HP:0011031) | 1.84883810 |
| 94 | Abnormality of T cell number (HP:0011839) | 1.81191574 |
| 95 | Stomach cancer (HP:0012126) | 1.80954023 |
| 96 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.77252382 |
| 97 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.76810752 |
| 98 | Abnormality of the pericardium (HP:0001697) | 1.76645905 |
| 99 | Polyneuropathy (HP:0001271) | 1.75837369 |
| 100 | Viral hepatitis (HP:0006562) | 1.73518058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.20694355 |
| 2 | MAP2K3 | 3.13084961 |
| 3 | FES | 2.85646140 |
| 4 | IRAK4 | 2.51677294 |
| 5 | CSK | 2.26737860 |
| 6 | MAP3K13 | 2.25636594 |
| 7 | TAOK3 | 2.25526144 |
| 8 | RIPK4 | 2.19682501 |
| 9 | ERN1 | 2.18315849 |
| 10 | PRPF4B | 2.18118834 |
| 11 | MAP3K11 | 2.13411895 |
| 12 | MAP3K7 | 2.10921893 |
| 13 | TAOK1 | 2.07710623 |
| 14 | TXK | 2.06339281 |
| 15 | TYK2 | 2.05464976 |
| 16 | GRK6 | 1.97013270 |
| 17 | BLK | 1.95984612 |
| 18 | TNK2 | 1.94855697 |
| 19 | MAP3K9 | 1.91126280 |
| 20 | MAP3K3 | 1.87455212 |
| 21 | BTK | 1.82693518 |
| 22 | TAOK2 | 1.75164861 |
| 23 | ZAP70 | 1.62767441 |
| 24 | MOS | 1.62087904 |
| 25 | SYK | 1.60671806 |
| 26 | TGFBR2 | 1.52052424 |
| 27 | IKBKE | 1.49208990 |
| 28 | BCKDK | 1.47619742 |
| 29 | HIPK2 | 1.45795252 |
| 30 | IKBKB | 1.39860500 |
| 31 | MAP3K1 | 1.39227091 |
| 32 | KSR2 | 1.35640955 |
| 33 | TBK1 | 1.34922420 |
| 34 | KIT | 1.34653955 |
| 35 | NME1 | 1.28981248 |
| 36 | EPHB1 | 1.26792097 |
| 37 | MATK | 1.26304816 |
| 38 | FRK | 1.25373920 |
| 39 | JAK3 | 1.20969962 |
| 40 | LRRK2 | 1.20452783 |
| 41 | LYN | 1.18464268 |
| 42 | NLK | 1.18270429 |
| 43 | MAP3K14 | 1.16245478 |
| 44 | TEC | 1.16063387 |
| 45 | JAK2 | 1.15001827 |
| 46 | PRKD2 | 1.12937596 |
| 47 | DYRK1B | 1.09834772 |
| 48 | ITK | 1.09325030 |
| 49 | HCK | 1.08650851 |
| 50 | TYRO3 | 1.07848316 |
| 51 | MARK2 | 1.06046516 |
| 52 | ARAF | 1.05542560 |
| 53 | LCK | 1.04326330 |
| 54 | MAP2K6 | 0.99818208 |
| 55 | JAK1 | 0.97407318 |
| 56 | MAP2K2 | 0.96609881 |
| 57 | FGR | 0.84968751 |
| 58 | PAK6 | 0.84919778 |
| 59 | DAPK2 | 0.82456451 |
| 60 | GRK7 | 0.81272176 |
| 61 | STK11 | 0.81237648 |
| 62 | CSF1R | 0.80699220 |
| 63 | CAMKK2 | 0.78924363 |
| 64 | EPHA3 | 0.73914365 |
| 65 | STK38 | 0.72058456 |
| 66 | CDK19 | 0.70176640 |
| 67 | YES1 | 0.67130366 |
| 68 | PTK2B | 0.65457545 |
| 69 | MAP2K4 | 0.61640080 |
| 70 | RAF1 | 0.61639621 |
| 71 | PRKAA2 | 0.60833330 |
| 72 | PRKCQ | 0.57582968 |
| 73 | STK16 | 0.55165503 |
| 74 | MAPK15 | 0.52416088 |
| 75 | PDK1 | 0.51834874 |
| 76 | STK10 | 0.48285787 |
| 77 | GRK5 | 0.45404917 |
| 78 | MARK3 | 0.44507868 |
| 79 | SGK2 | 0.43706327 |
| 80 | PDPK1 | 0.43425563 |
| 81 | MAP3K6 | 0.43083069 |
| 82 | RPS6KC1 | 0.40977694 |
| 83 | RPS6KL1 | 0.40977694 |
| 84 | MAP3K5 | 0.40888387 |
| 85 | SGK223 | 0.38545635 |
| 86 | SGK494 | 0.38545635 |
| 87 | PRKD1 | 0.38297721 |
| 88 | CHUK | 0.37945493 |
| 89 | RPS6KA6 | 0.37356065 |
| 90 | SIK2 | 0.37232535 |
| 91 | PINK1 | 0.35196691 |
| 92 | FYN | 0.34522168 |
| 93 | PTK6 | 0.34487587 |
| 94 | SGK3 | 0.33569218 |
| 95 | PIM1 | 0.33338522 |
| 96 | CAMKK1 | 0.30469764 |
| 97 | TESK2 | 0.30356020 |
| 98 | SIK3 | 0.29541681 |
| 99 | PIK3CG | 0.29206853 |
| 100 | ADRBK1 | 0.29180161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.16848831 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.94308223 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.80496327 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.55203965 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.48549270 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.42092546 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.35953896 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.30674163 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 2.00390214 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87546607 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85204164 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85133605 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80818481 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.78705247 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73546149 |
| 16 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68444556 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67967539 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.59901107 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59661851 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.56807591 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.53358455 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52482869 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.52323622 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46700287 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45074451 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42550610 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.37592301 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36382364 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34734521 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.34023968 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.27914349 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25389769 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.24462301 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.20678114 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18556552 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.17467236 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.15721952 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13724772 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.12540041 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.12505287 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12326740 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09088457 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06001603 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04383923 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.04202221 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03987678 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02191372 |
| 48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00075704 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 0.97512872 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96417186 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.96367839 |
| 52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96180675 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.91756176 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.90153638 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.89320516 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89127072 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85547582 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84796016 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.84686174 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.81395182 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80542005 |
| 62 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80207859 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78193416 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78191758 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76465826 |
| 66 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76252410 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.71633205 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.70823858 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70539026 |
| 70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69457172 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68513851 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 0.66236878 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64817220 |
| 74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.62258657 |
| 75 | Salmonella infection_Homo sapiens_hsa05132 | 0.61471747 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57539880 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56408122 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.55544506 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55070705 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.54159104 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54082873 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.47899009 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47492291 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47210948 |
| 85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47164707 |
| 86 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43533349 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43073573 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41714881 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41555713 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41195412 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39671811 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39432373 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37924065 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37416351 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35768485 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35519182 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34604631 |
| 98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33510041 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.32605270 |
| 100 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.32308008 |

